inspection – Page 258

Uncontrolled spreadsheet calculations during internal audit – warning letter risk explained

Understanding Risks Associated with Uncontrolled Spreadsheet Calculations During Internal Audits An emerging situation in pharmaceutical manufacturing can highlight risks to data integrity, specifically involving uncontrolled spreadsheet calculations during internal audits.…

Audit trail deletion identified during system validation – 483 observation breakdown

Analyzing an Audit Trail Deletion Incident Encountered During System Validation In the complex world of pharmaceutical manufacturing, ensuring data integrity is paramount to comply with regulatory standards and maintain trust…

Manual result transcription without verification during internal audit – 483 observation breakdown

Analyzing the Impact of Manual Result Transcription in Internal Audits and Responding Effectively In the realm of pharmaceutical manufacturing, ensuring data integrity during internal audits is paramount to maintaining compliance…

Media fill deviation not escalated during investigation – patient safety risk case study

Addressing Unreported Media Fill Deviations and Their Risks In a recent scenario within a pharmaceutical manufacturing facility, a critical media fill deviation went unreported, raising concerns about patient safety. The…

Contamination source misidentified during aseptic filling – regulatory enforcement outcome

Investigating Misidentified Contamination Sources in Aseptic Filling: A Case Study In the realm of pharmaceutical manufacturing, the integrity of sterile products is paramount. A recent case study illustrates a significant…

Bioburden excursion before filtration during cleaning verification – patient safety risk case study

Case Study: Managing Bioburden Excursion During Cleaning Verification Processes In the highly regulated pharmaceutical industry, ensuring the sterility of production environments is critical. A bioburden excursion detected before filtration during…

Unvalidated aseptic intervention during cleaning verification – regulatory enforcement outcome

Investigating Unvalidated Aseptic Interventions in Cleaning Verifications: A Case Study In the realm of pharmaceutical manufacturing, the integrity of aseptic processes is foundational to product quality and compliance. This case…

Unvalidated aseptic intervention during cleaning verification – patient safety risk case study

Case Study: Risks of Unvalidated Aseptic Intervention During Cleaning Verification In a recent scenario at a pharmaceutical manufacturing facility, an unvalidated aseptic intervention during the cleaning verification process led to…

Gowning deviation ignored during aseptic filling – regulatory enforcement outcome

Investigation of an Aseptic Filling Gowning Deviation Ignored: A Regulatory Perspective The pharma industry operates under stringent regulations to ensure product quality and patient safety. However, deviations can occur, impacting…

Unvalidated aseptic intervention during aseptic filling – patient safety risk case study

Exploring Unvalidated Aseptic Interventions During Aseptic Filling: A Case Study In a recent incident at a large pharmaceutical manufacturing facility, an unvalidated aseptic intervention during aseptic filling raised significant concerns…

Bioburden excursion before filtration during aseptic filling – regulatory enforcement outcome

Managing Bioburden Excursions in Aseptic Filling: A Case Study In the high-stakes environment of pharmaceutical manufacturing, maintaining sterility is paramount. A recent case of bioburden excursion before filtration during aseptic…

Cross-contamination detected post-release during aseptic filling – patient safety risk case study

Case Study on Post-Release Cross-Contamination during Aseptic Filling In a recent incident within a high-volume aseptic filling facility, cross-contamination was detected during a post-release quality control test, sparking significant patient…